Nesprin-2

Nesprin-2
Name	Nesprin-2
Genesymbol	SYNE2

Nesprin-2 Nesprin-2 is a large nuclear envelope protein implicated in nuclear architecture and mechanotransduction. It links the nuclear lamina to the cytoskeleton and is involved in processes associated with cellular positioning, signal transduction, and chromatin organization. Research on Nesprin-2 spans molecular cell biology, developmental biology, and clinical genetics, connecting to studies in nuclear mechanics, muscular dystrophy, cardiomyopathy, and cancer.

Structure and isoforms

Nesprin-2 is characterized by spectrin repeat arrays, a C-terminal KASH (Klarsicht/ANC-1/Syne homology) motif, and multiple alternative translation start sites that generate isoforms of varying molecular weight. Structural descriptions reference spectrin repeats reminiscent of those in Dystrophin, Spectrin family studies, and rod-like architectures studied in Electron microscopy and X-ray crystallography. Isoforms include large nesprin-2 giant variants and shorter isoforms lacking the KASH motif; isoform diversity parallels findings in studies of Alternative splicing mechanisms explored by groups such as those at the Broad Institute, Max Planck Society, and Cold Spring Harbor Laboratory. Comparative protein domain mapping often references datasets from the Human Genome Project, Ensembl, and UniProt.

Gene and regulation

The SYNE2 gene encoding Nesprin-2 is located on human chromosome 14 and features complex promoter usage, transcription factor binding, and alternative splicing. Regulatory elements and epigenetic marks are analyzed in consortia such as the ENCODE Project, Roadmap Epigenomics Project, and genome-wide association contexts like work by the Wellcome Trust. Transcriptional control links to transcription factors studied in laboratories at the National Institutes of Health and Harvard Medical School, while post-transcriptional regulation involves mechanisms examined by researchers at the Sanger Institute and the European Molecular Biology Laboratory. SYNE2 expression patterns have been profiled in resources including the GTEx Project, Human Protein Atlas, and developmental atlases from the Allen Institute for Brain Science.

Cellular localization and function

Nesprin-2 localizes to the outer nuclear membrane where it participates in LINC (linker of nucleoskeleton and cytoskeleton) complex formation, coordinating with nuclear lamins and cytoskeletal networks. Localization studies reference co-distribution with Lamin A/C characterized by groups at Columbia University, interaction with actin filaments similar to observations in Cell (journal) articles, and roles in nuclear positioning studied in model systems popular at the University of Cambridge and Stanford University. Functional assays implicate Nesprin-2 in mechanotransduction pathways investigated alongside signaling components described by researchers at Massachusetts Institute of Technology and University of California, San Francisco. Techniques from labs such as those at the European Molecular Biology Laboratory have used immunofluorescence, live-cell imaging pioneered at Janelia Research Campus, and super-resolution platforms developed at Max Planck Institute.

Interactions and binding partners

Nesprin-2 binds to SUN domain proteins to form the LINC complex, and interacts with cytoskeletal elements and nuclear envelope components. Key binding partners include SUN1, SUN2, and nuclear lamins studied in foundational work at institutions like Johns Hopkins University and Utrecht University. Interactome mapping often employs mass spectrometry workflows from facilities at the Proteomics Core Facility of major centers such as Rockefeller University and University of Oxford. Additional partners identified in screens include actin-binding proteins noted in publications from University of Pennsylvania and signaling adaptors referenced in studies at Yale University and University of Chicago. Disease-associated interactors are investigated in clinical research settings including Mayo Clinic and Cleveland Clinic.

Role in development and disease

Nesprin-2 contributes to tissue morphogenesis, nuclear migration, and cellular polarity during development studied in model organisms used at laboratories like European Molecular Biology Laboratory, Max Planck Institute, and Howard Hughes Medical Institute-affiliated groups. Mutations and dysregulation of SYNE2 have been associated with cardiomyopathy, muscular dystrophy phenotypes, and cancer progression reported in clinical series from institutions including Mayo Clinic, Mount Sinai Hospital, and Johns Hopkins Hospital. Pathogenic mechanisms intersect with pathways involving LMNA mutations described in landmark studies at University of Toronto and Brigham and Women's Hospital. Epidemiological correlations reference datasets compiled by consortia such as the UK Biobank and disease registries maintained by National Institutes of Health programs.

Experimental studies and models

Experimental interrogation of Nesprin-2 employs cell lines, patient-derived induced pluripotent stem cells, and animal models including mouse knockouts and zebrafish morphants used by research teams at Harvard University, University of California, Berkeley, and Karolinska Institutet. Techniques include CRISPR/Cas9 genome editing popularized by labs at Broad Institute and MIT, live imaging platforms from Janelia Research Campus, and biophysical assays developed in collaborations with engineering groups at Massachusetts Institute of Technology and ETH Zurich. Translational studies and therapeutic explorations are pursued in academic-industry partnerships involving biotech firms in Cambridge, Massachusetts and San Francisco, and clinical trial networks coordinated by National Institutes of Health.

Category:Proteins